CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 138 filers reported holding CHINA BIOLOGIC PRODS INC in Q2 2016. The put-call ratio across all filers is 1.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,935,000 | +35.1% | 17,116 | +19.6% | 0.00% | 0.0% |
| Q1 2017 | $1,432,000 | +7.4% | 14,309 | +15.4% | 0.00% | 0.0% |
| Q4 2016 | $1,333,000 | -1.0% | 12,403 | +14.7% | 0.00% | 0.0% |
| Q3 2016 | $1,346,000 | +17.9% | 10,818 | +0.6% | 0.00% | 0.0% |
| Q2 2016 | $1,142,000 | -5.1% | 10,749 | +2.3% | 0.00% | 0.0% |
| Q1 2016 | $1,203,000 | -11.6% | 10,512 | +9.9% | 0.00% | 0.0% |
| Q4 2015 | $1,361,000 | +72.9% | 9,562 | +9.0% | 0.00% | – |
| Q3 2015 | $787,000 | -27.1% | 8,773 | -6.5% | 0.00% | -100.0% |
| Q2 2015 | $1,079,000 | +34.2% | 9,378 | +11.3% | 0.00% | – |
| Q1 2015 | $804,000 | +70.3% | 8,424 | +19.8% | 0.00% | – |
| Q4 2014 | $472,000 | +63.9% | 7,030 | +31.3% | 0.00% | – |
| Q3 2014 | $288,000 | +39.8% | 5,356 | +15.6% | 0.00% | – |
| Q2 2014 | $206,000 | – | 4,633 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WARBURG PINCUS LLC | 10,989,200 | $1,049,578,000 | 7.88% |
| RUDMAN ERROL M | 110,201 | $10,525,000 | 3.65% |
| Ativo Capital Management LLC | 59,789 | $5,710,000 | 2.24% |
| OBERWEIS ASSET MANAGEMENT INC/ | 56,200 | $5,368,000 | 1.51% |
| Granite Point Capital Management, L.P. | 40,000 | $3,820,000 | 1.40% |
| Cormorant Asset Management, LP | 76,500 | $7,307,000 | 1.13% |
| Spark Investment Management LLC | 52,800 | $5,031,000 | 0.70% |
| Grandeur Peak Global Advisors, LLC | 33,050 | $3,157,000 | 0.67% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 198,454 | $18,954,000 | 0.66% |
| Visium Asset Management, LP | 438,008 | $41,834,000 | 0.62% |